Award of Share Options

RNS Number : 8997K
hVIVO plc
21 April 2015
 



For immediate release: 21 April 2015

 

HVIVO PLC

("hVIVO" or the "Company")

 

Award of Share Options

hVIVO plc (AIM: HVO), the pioneer of human challenge models of disease, announces that on 21 April 2015 it awarded the following options over ordinary shares of 5.0p each in the Company to certain Directors:

Name

Position

Number of Share Options Awarded

Exercise price per Share

Date of Vesting

Percentage of issued ordinary share capital

Kym Denny

Chief Executive Officer

111,193

337.25p

21 April 2018

0.16%

Graham Yeatman

Chief Financial & Business Officer

88,955

337.25p

21 April 2018

0.13%

 

 For further information please contact:

hVIVO plc                                                                                         +44 207 756 1300

 

Kym Denny (CEO)

Graham Yeatman (FD)

 

Media Enquiries                                                      +44 203 021 3933 / +44 7854 979 420

 

Colin Paterson (Director of Marketing, Communication and Public Relations)

 

              

Numis Securities Limited                                                                      +44 207 260 1000

 

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black / Michael Burke (Corporate Broking)

 

 

Notes to Editors:

hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases.  Based in the UK, hVIVO has conducted over 40 clinical studies, involving more than 1950 volunteers for a range of leading industry, governmental and academic clients.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUASSRVAASUAR

Companies

Hvivo (HVO)
UK 100

Latest directors dealings